Have a BMI of 27 or Higher? Researchers are studying an investigational once-daily oral tablet for adults with Type 2 diabetes and excess weight 

Requirements

Participants must meet the following inclusion criteria to be eligible for this clinical trial:

• Male and female adults18 and older
• Affected by excess weight or obesity
• BMI ≥27
• Diagnosed with Type 2 Diabetes treated with up to 3 oral medications
  • Examples:
  • Metformin 
  • SGLT-2 inhibitors (e.g., Jardiance®, Farxiga®, Invokana®) 
  • Sulfonylureas (e.g., glipizide, glimepiride, glyburide) 
  • TZDs (e.g., pioglitazone) 
  • Meglitinides/glinides (e.g., repaglinide, nateglinide) 
  • Alpha-glucosidase inhibitors (e.g., acarbose, miglitol)
• HbA1c 6.5%–10.5% 
• Have a history of at least 1 self-reported unsuccessful dietary effort to lose body weight 
• Have previously attempted weight loss through diet and exercise 
• Are interested in participating in a clinical research study evaluating an investigational oral medication 
• Are willing to attend study visits and follow the study requirements 
• Additional eligibility requirements apply and will be reviewed by the study team
• Health status is further evaluated by reviewing medical history, screening assessment and visit with physician
• Don’t meet one of the criteria above? You may qualify for another study – please explore the full list at here https://trialmed.com/find-a-study/

About study

Type 2 diabetes and excess weight often occur together and can increase the risk of serious health conditions, including heart disease, high blood pressure, and high cholesterol. While healthy eating, physical activity, and currently available medications can help manage these conditions, researchers continue to study new treatment options that may provide additional benefits. 

This Phase 3 clinical research study is evaluating an investigational oral GLP-1 medication. Unlike many GLP-1 medications that are given by injection, the study medication is taken by mouth once each day. 

Researchers will evaluate the study medication alongside healthy lifestyle changes to better understand its safety and effectiveness. The study will also examine changes in body weight, blood sugar, blood pressure, cholesterol levels, and overall metabolic health. 

Qualified participants receive study-related care at no cost and may receive compensation for time and travel. 

Participation is voluntary, and you may leave the study at any time.